Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Mark Foletta Insider Profile

4 Followers

Mark Foletta, Director at Dexcom, holds 55.18K shares in Dexcom (Ticker: DXCM), holds 0.00 shares in Biocept (Ticker: BIOCQ), holds ― shares in Enanta Pharmaceuticals (Ticker: ENTA).

Mark Foletta's Trading History

DXCMDexcom		Aug 04, 2026DirectorUninformative Sell330.64K$4.54M
AMNAMN Healthcare Services		Jun 17, 2026DirectorUninformative Sell114.33K$844.07K
FBRXForte Biosciences		May 29, 2019―Uninformative Buy21.45K$1.16M
RGLSRegulus		Dec 06, 2017―Uninformative Buy64.00K$668.39K
~AMBIAmbit		――――
ENTAEnanta Pharmaceuticals		―Director――
BIOCQBiocept		―Interim CFO――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Mark Foletta insider profile FAQ

What is the percentage of profitable transactions made by Mark Foletta?
The percentage of profitable transactions made by Mark Foletta is 18%.
What is the average return per transaction made by Mark Foletta?
The average return per transaction made by Mark Foletta is -32.30%.
What stocks does Mark Foletta hold?
Mark Foletta holds: DXCM, BIOCQ, ENTA, FBRX, RGLS, AMN, ~AMBI stocks.
What was Mark Foletta’s latest transaction?
Mark Foletta’s latest transaction was an Uninformative Sell of $330.64K.
What was Mark Foletta's most profitable transaction?
Mark Foletta’s most profitable transaction was an Informative Sell of DXCM stock on September 9, 2016. The return on the trade was 23.30%.
What is Mark Foletta's role in Dexcom?
Mark Foletta's role in Dexcom is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.